Virginie Bernard

The clonal and mutational evolution spectrum of primary triple-negative breast cancers

Sohrab P. Shah, Andrew Roth, Rodrigo Goya et al. · Nature · 2012 · 2K citations

Breast Oncology, Tumor Heterogeneity, Medicine +10

Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial

Christophe Le Tourneau, Jean-Pierre Delord, Anthony Gonçalvès et al. · The Lancet Oncology · 2015 · 1.1K citations

Advanced Cancer, Drug Targeting, Oncology +12

Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations

Thomas F. Eleveld, Derek A. Oldridge, Virginie Bernard et al. · Nature Genetics · 2015 · 543 citations

Receptor Tyrosine Kinase, Pathology, Neuroblasts +5

Circulating tumor DNA changes for early monitoring of anti-PD1 immunotherapy: a proof-of-concept study

Luc Cabel, Francesca Riva, Vincent Servois et al. · Annals of Oncology · 2017 · 336 citations

NaLi-H1: A universal synthetic library of humanized nanobodies providing highly functional antibodies and intrabodies

Sandrine Moutel, Nicolas Béry, Virginie Bernard et al. · eLife · 2016 · 314 citations · Full text

Nanotherapeutics, Engineering, Immunology +20